SVNT: Summary for Savient Pharmaceuticals Inc - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 1:29am EST - Canadian Markets open in 8 hours and 1 minute.

To create a watchlist or portfolio of shares, Sign-in or Register

Savient Pharmaceuticals, Inc. (SVNT)

On Feb 9: 12.81 USD

0.36 (2.89%)

MORE ON SVNT

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Savient Pharmaceuticals Inc (NGM:SVNT) Delayed quote data

After Hours: 12.78

0.03 (0.26%) as of 4:52pm EST on 02/09/10

Last Trade:	12.81 USD
Trade Time:	Feb 9
Change:	0.36 (2.89%)
Prev Close:	12.45
Open:	12.78
Bid:	11.66 x 100
Ask:	13.52 x 100
1y Target Est:	17.00

Day's Range:	12.46 - 12.95
52wk Range:	3.45 - 16.62
Volume:	743,141
Avg Vol (3m):	1,041,660
Market Cap:	853.48M
P/E (ttm):	N/A
EPS (ttm):	-2.01
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add SVNT to Portfolio

Download Data

HEADLINES

•	Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
	PRNewswire (Mon, Feb 8)

•	Coverage initiated on Savient Pharma by Soleil
	Briefing.com (Thu, Jan 28)

•	Study: orphan drug applications doubled in 200s
	AP (Wed, Jan 20)

•	Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
	PRNewswire (Fri, Jan 8)

•	Friday Options Update: SVNT, JBLU, ROST, RVSN, MRVL, RYL, ARIA, WLP
	at Seeking Alpha (Fri, Dec 18)

•	Savient To Present at the 28th Annual JP Morgan Healthcare Conference
	PRNewswire (Thu, Dec 10)

•	SAVIENT PHARMACEUTICALS INC Financials
	EDGAR Online Financials (Fri, Nov 13)

•	SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
	EDGAR Online (Mon, Nov 9)

•	SAVIENT PHARMACEUTICALS INC Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities
	EDGAR Online (Thu, Oct 22)

•	SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Thu, Oct 15)

•	SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Fri, Oct 9)

More Headlines for SVNT...

ANALYST

EPS Est (next year) (Dec-09) :	-1.83
EPS Est (in 2 years) (Dec-10) :	-0.87
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing, manufacturing, and marketing pharmaceutical products that target unmet medical needs.

Full Company Profile

Add to Portfolio

Email to a Friend

•